AI Article Synopsis

  • Infantile Epileptic Spasm Syndrome (IESS) is a serious condition in infants that leads to hard-to-treat seizures and can result in intellectual disabilities.
  • The ketogenic diet therapy (KDT) is a promising non-drug treatment that has been shown to effectively reduce seizures and enhance cognitive outcomes for infants with IESS.
  • Recent research highlights the expanding role of KDT in treating various neurological disorders, as well as the need for further studies on its mechanisms and applications.

Article Abstract

Infantile Epileptic Spasm Syndrome (IESS) is a group of infantile spasm syndromes of various etiologies that typically present in early infancy, predispose to refractory epilepsy, and leave intellectual disability. Ketogenic diet therapy (KDT) is a non-pharmacologic treatment modality for medically refractory IESS. Recent scientific evidence supported the efficacy, safety, and tolerability of KDT for the treatment of IESS. KDT not only reduces the frequency of seizures in infants with IESS, but also improve their cognition and long-term prognosis. Recently, it has also received increasing attention as a potential treatment for neurological disorders. This reviewed the recent research progress of KDTs for the treatment of IESS, and discussed the different types and the mechanisms of KDTs, the expansion of KDT applications, the influencing factors, and future research issues.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576165PMC
http://dx.doi.org/10.3389/fped.2024.1472982DOI Listing

Publication Analysis

Top Keywords

treatment iess
8
iess
5
ketogenic diets
4
diets therapy
4
therapy management
4
management epileptic
4
epileptic spasms
4
spasms syndrome
4
syndrome infantile
4
infantile epileptic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!